Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

National Health Investors Inc Raises FY 2013 FFO Guidance-Conference Call


Monday, 6 May 2013 05:00pm EDT 

National Health Investors Inc announced that for fiscal 2013, it expects normalized FFO to be in a range of $3.42 to $3.50 per diluted share. According to I/B/E/S Estimates, analysts were expecting the Company to report FFO of $3.40 for fiscal 2013. 

Company Quote

66.28
-0.27 -0.41%
28 Nov 2014